QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing
RecruitingNot applicableNCT03434392
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
Quantitative Sensory Testing (QST) is a novel investigative technique used in other pain conditions to evaluate patterns of chronic pain, and in this study will be used to elucidate pain patterns in patients with Chronic Pancreatitis (CP). QST uses a specific series of standardized stimulations to map the pain system. QST has the potential to change and improve the treatment paradigm for patients with CP and may eventually be able to predict response to invasive CP therapies.
Study details
- Official title
- QST Study: Predicting Treatment Response in Chronic Pancreatitis Using Quantitative Sensory Testing
- Conditions
- Interventions
- Diagnostic test: Quantitative Sensory Test 1
- Diagnostic test: Quantitative Sensory Test 2
- Diagnostic test: Quantitative Sensory Test 3
- Sponsor
- Anna Evans Phillips
- Collaborators
- Johns Hopkins University; Aalborg University
- Organization
- University of Pittsburgh
- Start date
- 2017-10-24
- Primary completion
- 2030-06-30
- Sex
- All
- Age range
- from 18 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- United States
- Total sites listed
- 2
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Subjects with no pancreatic disease and no abdominal pain, or patients with a diagnosis of functional dyspepsia. * Subjects are 18 years or older in age * Subjects must be able to read and understand the study information. * Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study. * Subject is willing and able to comply with the scheduled visits, questionnaires, treatment plan, and other study procedures. 2. Suspected CPs Inclusion Criteria * Subjects are 18 years or older in age * Subjects with a) Indeterminate CP (Cambridge 1 or 2 on CT scan or MRI/MRCP) who have abdominal pain without prior history of AP, or b) those with acute (AP) or recurrent acute pancreatitis (RAP) who have recovered from their attack(s) of AP, whose imaging studies are either normal or show changes consistent with Cambridge classification of 1 or 2, and they have ongoing abdominal pain. Both diabetic and non-diabetic subjects will be allowed to enter the study. * Subjects must be able to read and understand the study information. * Subjects must suffer from abdominal pain suspected to be pancreatic origin with an intensity above 3 on the visual analogue scale (VAS, where 0=no pain and 10= intolerable pain), and meet the criteria for chronic pain (pain ≥ 3 days per week for at least 3 months). * Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study. * Subjects willing and able to comply with the scheduled visits, questionnaires, and other study procedures. 3. Definite Chronic Pancreatitis - Inclusion Criteria * Subjects are 18 years or older in age * Subjects will have a prior confirmed diagnosis of CP on CT scan or MRI/MRCP according to Cambridge Classification (grade 3 or 4). Both diabetic and non-diabetic subjects will be allowed to enter the study. * Subjects must be able to read and understand the study information. * Personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the study. * Subjects willing and able to comply with the scheduled visits, questionnaires, and other study procedures. 4. Sphincter of Oddi Dysfunction (SOD) Type 1 or Type 2 Inclusion Criteria * Subjects are 18 years or older in age * Subjects have prior diagnosis of Type 1 or Type 2 Sphincter of Oddi Dysfunction (subjects with biliary pain accompani…
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03434392